Perfusion continue de rémifentanil et propofol en anesthésie intraveineuse à objectif de concentration au cours de la chirurgie coronaire du sujet âgé : comparaison avec l’alfentanil et le propofol en perfusion continue

Gardellin, M.; Durand, M.; Maitrasse, B.; Chavanon, Olivier; Robin, Sylvaine; Blin, Dominique; P, Girardet

doi:10.1016/j.annfar.2004.08.008

Cited by 2 publications

(2 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We screened titles and abstracts to identify potentially eligible studies and retrieved 41 manuscripts for full-text review. Twenty-six of those studies were excluded: 4 studies were not in English or Chinese, [13–16] 12 did not include the relevant outcomes for systematic review, [17–28] 5 were not set in the ICU, [29–33] 3 studies using remifentanil versus non-opioid for sedation, [34–36] and 2 studies are not RCTs [37,38] . In total, 15 studies [39–53] were eligible and included in this systemic review, which ultimately included 1233 subjects.…”

Section: Resultsmentioning

confidence: 99%

Comparison between remifentanil and other opioids in adult critically ill patients

et al. 2021

View full text Add to dashboard Cite

Background and aims: To identify the efficacy and safety of remifentanil when compared with other opioids in adult critically ill patients. Methods: We searched for studies in the Cochrane Library, MEDLINE, and EMBASE that had been published up to May 31st, 2019. Randomized clinical trials using remifentanil comparing with other opioids for analgesia were included. Two reviewers independently applied eligibility criteria, assessed quality, and extracted data. Duration of mechanical ventilation was the primary outcome, and secondary outcomes included weaning time, intensive care unit (ICU), length of stay (LOS), hospital LOS, mortality, side effects, and costs. Results: Fifteen studies with 1233 patients were included. Remifentanil was associated with a significant reduction in the duration of mechanical ventilation in the adult ICU patients when compared with other opioids ( P = .01). Remifentanil also reduced the weaning time ( P = .02) and the ICU LOS when compared with other opioids ( P = .01). There was no difference in the hospital LOS ( P = .15), side effects ( P = .39), and mortality ( P = .79) between remifentanil and other opioids, what's more, remifentanil increased the costs of anesthesia ( P < .001) but did not increase cost of hospitalization ( P = .30) when comparing with other opioids. Conclusions: Remifentanil reduced the duration of mechanical ventilation, weaning time, and ICU LOS when compared with other opioids in adult critically ill patients. Higher quality RCTs are necessary to prove our findings. PROSPERO registration number: CRD42016041438.

show abstract

Section: Resultsmentioning

confidence: 99%

Comparison between remifentanil and other opioids in adult critically ill patients

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Therefore, sedation in spontaneous ventilation and anesthesia in elderly and fragile patients represents the main indications of TCI [ 28 ]. In fact, when comparing a standard anesthesia protocol with continuous infusion of propofol and remifentanil to an anesthesia procedure with propofol in TCI mode and continuous infusion remifentanil in a series of 338 patients, undergoing coronary surgery, the authors showed that the tracheal extubation was earlier in the TCI group, but patients in this group required more transfusion and vaso-active drugs [ 31 ]. In another prospective study that compares two modes of administration (manual and TCI) of propofol and alfentanil, the authors randomized 220 patients undergoing sedation for gastrointestinal endoscopy.…”

Section: Discussionmentioning

confidence: 99%

Anesthesia for endoscopic retrograde cholangiopancreatography: target-controlled infusion versus standard volatile anesthesia

Motiaa¹,

Bensghir²,

Jaafari³

et al. 2016

aog

View full text Add to dashboard Cite

BackgroundEndoscopic retrograde cholangiopancreatography (ERCP) is a technique used both for diagnosis and for the treatment of biliary and pancreatic diseases. ERCP has some anesthetic implications and specific complications. The primary outcome aim was to compare two protocols in terms of time of extubation. We also compared anesthetic protocols in terms of hemodynamic and respiratory instability, antispasmodics needs, endoscopist satisfaction, and recovery room stay.MethodsPatients were randomized into two groups standard anesthesia group (Gr: SA) in whom induction was done by propofol, fentanyl and cisatracurium and maintenance was done by a mixture of oxygen, nitrousoxide (50%:50%) and sevoflurane; and intravenous anesthesia group to target concentration (Gr: TCI) in whom induction and maintenance of anesthesia were done with propofol with a target 0.5-2 μg/mL, and remifentanil with a target of 0.75-2 ng/mL.Results90 patients were included. Extubation time was shorter in Gr: TCI, 15±2.6 vs. 27.4±7.1 min in Gr: SA (P<0.001). The incidence of hypotension was higher in GrL: SA (P=0.009). Satisfaction was better in Gr: TCI (P=0.003). Antispasmodic need was higher in Gr: SA (P=0.023). Six patients in Gr: SA group had desaturation in post-anesthesia care unit (PACU) versus one patient from Gr: TCI (P=0.049). Patients in Gr: TCI had shorter PACU stay 40.2±7.3 vs. 58.7±12.4 min (P<0.001).ConclusionThe use of TCI mode allows better optimization of general anesthesia technique during ERCP.

show abstract

Perfusion continue de rémifentanil et propofol en anesthésie intraveineuse à objectif de concentration au cours de la chirurgie coronaire du sujet âgé : comparaison avec l’alfentanil et le propofol en perfusion continue

Cited by 2 publications

References 31 publications

Comparison between remifentanil and other opioids in adult critically ill patients

Comparison between remifentanil and other opioids in adult critically ill patients

Anesthesia for endoscopic retrograde cholangiopancreatography: target-controlled infusion versus standard volatile anesthesia

Contact Info

Product

Resources

About